Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Frederick L. Ruberg, MD
Healthcare Professional Director
Advanced Cardiac Imaging Program
Boston Medical Center
732 Harrison Ave
Boston, Massachusetts, United States
Frederick L. Ruberg, MD is an Associate Professor of Medicine and Radiology at Boston University (BU) School of Medicine and clinical cardiologist at Boston Medical Center (BMC), specializing in cardiac imaging and infiltrative heart disease. He attended the University of Pennsylvania School of Medicine, completed internal medicine training at Brigham and Women’s Hospital, cardiovascular disease fellowship at Boston Medical Center/Boston University School of Medicine, and a fellowship in cardiovascular magnetic resonance imaging at Beth Israel Deaconess Medical Center.
Dr. Ruberg has an active clinical practice as the senior cardiologist in the BU/BMC Amyloidosis Center. He is Associate Chief of Cardiovascular Medicine for Academic Affairs, Associate Director of the Cardiovascular Medicine Fellowship program, director of the cardiac MRI program at BMC as well as the Integrated Pilot Grants Program of the Boston University Clinical and Translational Science Institute.
Dr. Ruberg is also an Associate Editor of Circulation: Cardiovascular Imaging and a Fellow of the American Heart Association and American College of Cardiology. His NIH and industry funded research program focuses on the application of non-invasive cardiac imaging for amyloidosis identification and clinical care optimization. Dr. Ruberg’s active area of research interest is ATTR amyloidosis. Current projects involve the application of pyrophosphate imaging for detection of ATTR amyloidosis, application of echocardiographic strain imaging as a disease marker, evaluation of treatments of ATTR amyloidosis, and validation of point of care diagnostic tools for cardiac amyloidosis identification in the outpatient clinic. Dr. Ruberg is committed to raising awareness of cardiac amyloidosis among clinicians and the general population so as to afford early diagnosis and enhanced access to disease modifying therapies.
Representative Publications:
myBinderRelated Content
-
Hepatic Amyloidosis: A Cause of Rapidly Progressive JaundiceAn 83-year-old man presented with an acu...
-
Kevin R. Anderson, MDDr. Kevin R. Anderson received his medic...
-
David Wolinsky, MDDavid Wolinsky, MD is a graduate of ...
-
New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac AmyloidosisSystemic amyloidoses are rare and protei...
-
Transthyretin Cardiac Amyloidosis in Black AmericansTransthyretin-related cardiac amyloidosi...
-
Scott D. Jerome, DODr. Jerome is a board certified cardio...
-
Right Ventricular Longitudinal Strain: A Tool for Diagnosis and Prognosis in Light-Chain AmyloidosisObjectives: Light-chain (AL) amyloidosi...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
